Most Recent Articles by Suzanne Bujara
The transition from pediatric to adult care for type 1 diabetes should be a gradual process, with a plan to make the change when the patient is ready, not at a pre-determined time.
Environmental causes of T2D and other metabolic disorders are often overlooked; a new body of evidence, however, is changing the clinical thinking about mitigating these effects on those at high risk of T2D.
Knowing that certain characteristics increase the risk for dermatology patients who may have metabolic syndrome will enable clinicians to identify patients who may have specific cardiovascular risks.
Previous trials suggested that vitamin D supplementation reduces rates of both influenza and other respiratory infections.
High-dose atorvastatin therapy can reduce inflammation and improve quality of life in patients with severe bronchiectasis and P aeruginosa infection.
Endocrinology Advisor Articles
- ADA Releases Updated Guidelines for Managing Pediatric Type 1 Diabetes
- Relationship Between HbA1c and Coronary Artery Disease
- Intermittent vs Continuous Energy-Restricted Diet: Effects on Glycemic Control and Weight Loss T2D
- The Obesity Paradox in Diabetes: Conceptual and Clinical Approaches
- Nonfunctioning Adrenal Incidentaloma Associated With Metabolic Syndrome
- Self-Administered Contraceptive Vaginal System Approved for Up to 1 Year of Use
- Predictors of Weight Loss in Postpartum Women With Gestational Diabetes
- Genetic Screening May Predict Osteoporosis, Fracture Risk
- DPP-4 Inhibitors and Incidence of Rheumatoid Arthritis in Type 2 Diabetes
- AMA Adopts Policy on Augmented Intelligence